Skip to main content
915 TLDR
Health
1 read

Oregon Doctor Cleared of Hantavirus After Cruise Ship Incident

KVIA••CNN
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

Dr. Stephen Kornfeld, a 69-year-old oncologist from Oregon, has tested negative for hantavirus after initially showing faint positive results while aboard the MV Hondius cruise ship. He was hospitalized in a biocontainment unit in Nebraska but has now been moved to a quarantine unit with 15 other American passengers, all of whom are currently symptom-free. The World Health Organization reports a total of 11 hantavirus cases linked to the ship, and while the risk to the general public remains low, health officials are monitoring at least 19 other individuals across 10 states who may have been exposed. Passengers are encouraged to stay in quarantine for health monitoring, as the virus has a long incubation period.

Key Details: • Dr. Kornfeld tested negative after initial faint positive results. • He is now in a quarantine unit with 15 other passengers. • The CDC recommends monitoring for 42 days for those exposed. • 19 other individuals in 10 states are being monitored for exposure.

health cdc quarantine cruise-ship hantavirus

People & Organizations

CDCWorld Health OrganizationAtlantaNebraskaMV HondiusStephen KornfeldDavid Fitter

Related Articles

KTSM•Jun 21

New Research Links Hearing Loss to Increased Alzheimer's Risk

As the population ages, the number of individuals diagnosed with Alzheimer's disease is projected to double by 2060, highlighting the urgent need for early detection and intervention. Recent studies suggest that hearing loss may be a significant warning sign of cognitive decline, prompting researchers to explore its implications for Alzheimer's risk. Understanding these connections could lead to better preventative strategies for those at risk. This research is crucial for healthcare providers and families in El Paso and beyond, as it emphasizes the importance of addressing hearing health as part of cognitive wellness.

Health
1 min read
El Paso Matters•Jun 21

El Paso Sees Decline in Accidental Deaths and Drug Overdose Trends in 2025

The latest report from the El Paso County Office of the Medical Examiner reveals a significant 32% decrease in accidental deaths from 2023 to 2025, primarily due to reductions in motor vehicle accidents and drug overdoses. Notably, cocaine-related deaths have surged, surpassing fentanyl for the first time since 2019, with 60 deaths attributed to cocaine last year. Cardiovascular disease remains the leading cause of sudden natural deaths, with high diabetes rates contributing to this trend. The report highlights the ongoing public health challenges in El Paso, including mental health issues among youth, as suicide rates remain stable but concerning, particularly among boys aged 11-18. Residents are encouraged to utilize local mental health resources.

Health
1 min read
KTSM•Jun 20

Medicare Initiates Pilot Program for Expanded Access to GLP-1 Medications

Medicare has announced a pilot program aimed at enhancing access to GLP-1 medications, which are commonly used for diabetes and weight management. This program will be operational from July 1, 2026, through December 31, 2027. The initiative is significant as it seeks to address the growing need for effective treatments in managing chronic conditions, potentially benefiting numerous patients. Stakeholders in the healthcare community should prepare for the changes and consider how this may affect patient care and medication availability.

Health
1 min read
KTSM•Jun 20

Medicare's New Pilot Program to Enhance Access to GLP-1 Medications

Medicare has announced a pilot program aimed at increasing access to GLP-1 medications, which are commonly used for diabetes and weight management. This demonstration will commence on July 1, 2026, and continue until December 31, 2027. The initiative is significant as it addresses the growing demand for these treatments, potentially benefiting many patients who struggle to afford them. Residents should be aware of this upcoming program, as it could impact their healthcare options and costs related to GLP-1 drugs.

Health
1 min read